H7925

Amends current law on controlled substances to permit psilocybin to be cultivated within a person's residence for personal use and contingent on the Food and Drug Administration (FDA) program, mandates that RI DOH establishes rules regulations.

Introduced·2/27/26
Introduced Text

Rhode Island H7925 allows personal cultivation of psilocybin for personal use and mandates health department rules contingent on FDA actions.

Rhode Island H7925 amends the state's controlled substances law to permit individuals to cultivate psilocybin within their residence for personal use. This change is contingent on the Food and Drug Administration (FDA) rescheduling psilocybin. If the FDA reschedules psilocybin, the Rhode Island Department of Health must establish rules and regulations for its cultivation, distribution, and medical prescription.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health & Human Services Committee
Next
Committee decision

Sponsors

DDDDDDDDDD
10
0
Democratic CaucusRepublican Caucus

History

Feb 27

House

Introduced, referred to House Health & Human Services